,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,23,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
11,25,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
12,29,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
13,33,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
14,35,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
15,37,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
16,39,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
17,45,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
18,47,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
19,51,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
20,53,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
21,55,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
22,57,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
23,59,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
24,61,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
25,63,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
26,65,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
27,67,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
28,69,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
29,71,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
30,73,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
31,75,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
32,77,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
33,79,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
34,81,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
35,103,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
36,105,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
37,107,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
38,113,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
39,115,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
40,119,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
41,123,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
42,125,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
43,129,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
44,131,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
45,133,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
46,135,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
47,139,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
48,141,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
49,145,1,1,,545430,10207,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
50,155,1,1,,545430,10207,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
51,157,1,1,,545430,10207,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
52,161,1,1,,545430,10207,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
53,165,1,1,,545430,10207,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
54,167,1,1,,545430,10207,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
55,175,1,1,,545430,10207,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
56,248,1,1,,545430,10207,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
57,256,1,1,,545430,10207,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
58,328,1,1,,545430,10207,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
59,351,1,4,,7636361,10207,Active,,,,,Tubulin destabilizers,Other,,
60,1376,1,2,,46501246,10207,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
61,1385,2,2,,46501246,10207,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
62,1422,1,1,,46501246,10207,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
63,1465,1,1,,46501246,10207,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
64,1469,1,1,,26756894,10207,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
65,1469,1,1,,26756895,10207,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
66,1477,1,1,,26756894,10207,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
67,1479,1,2,,26756894,10207,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
68,1479,1,2,,26756895,10207,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
69,1490,2,1,,26756894,10207,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
70,1511,1,3,,46501246,10207,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
71,1529,1,1,,46501246,10207,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
72,1530,1,1,,46501246,10207,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
73,1531,1,1,,46501246,10207,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
74,1532,1,1,,46501246,10207,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
75,1554,1,1,,46501246,10207,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
76,1621,1,2,,46501246,10207,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
77,1626,1,2,,46501246,10207,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
78,1662,1,2,,46501246,10207,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
79,1663,1,2,,46501246,10207,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
80,1672,1,3,,46501246,10207,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
81,1766,1,1,,26756894,10207,Inconclusive,18860839.0,4221.0,7.0795,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
82,1766,1,1,,26756894,10207,Inconclusive,56550039.0,4297.0,7.0795,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
83,1768,1,1,,26756894,10207,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
84,1768,1,1,,26756894,10207,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
85,1813,1,2,,46501246,10207,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
86,1814,1,2,,46501246,10207,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
87,1832,2,1,,46501246,10207,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
88,1850,2,1,,46501246,10207,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
89,1863,2,1,,46501246,10207,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
90,1875,2,1,,46501246,10207,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
91,1885,2,1,,46501246,10207,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
92,1899,1,3,,46501246,10207,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
93,1903,2,3,,46501246,10207,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
94,1906,1,3,,46501246,10207,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
95,1910,1,2,,46501246,10207,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
96,1947,1,2,,46501246,10207,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
97,1950,1,3,,46501246,10207,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
98,1956,1,1,,46501246,10207,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
99,1962,1,2,,46501246,10207,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
100,1974,1,2,,46501246,10207,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
101,1979,1,1,,46501246,10207,Inactive,994798.0,,,,Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound,Screening,,
102,1987,1,2,,46501246,10207,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
103,2016,1,3,,46501246,10207,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
104,2023,1,3,,46501246,10207,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
105,2025,1,3,,46501246,10207,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
106,2029,1,3,,46501246,10207,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
107,2052,2,1,,46501246,10207,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
108,2057,1,2,,46501246,10207,Active,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
109,2066,1,4,,46501246,10207,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
110,2094,1,2,,46501246,10207,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
111,2094,1,2,,46501246,10207,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
112,2094,1,2,,46501246,10207,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
113,2097,1,2,,46501246,10207,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
114,2098,1,1,,46501246,10207,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
115,2099,1,1,,46501246,10207,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
116,2101,1,1,,26756894,10207,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
117,2107,1,1,,26756894,10207,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
118,2112,1,1,,26756894,10207,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
119,2129,1,2,,46501246,10207,Active,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
120,2130,1,3,,46501246,10207,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
121,2156,2,2,,46501246,10207,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
122,2166,1,2,,46501246,10207,Active,20336335.0,598.0,,,"Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
123,2168,1,2,,46501246,10207,Active,78070770.0,4170.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
124,2174,1,3,,46501246,10207,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
125,2177,1,3,,46501246,10207,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
126,2216,1,3,,46501246,10207,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
127,2221,1,2,,46501246,10207,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
128,2227,1,2,,46501246,10207,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
129,2234,1,2,,46501246,10207,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
130,2235,1,2,,46501246,10207,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
131,2237,1,2,,46501246,10207,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
132,2239,1,2,,46501246,10207,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
133,2247,1,2,,46501246,10207,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
134,2280,2,3,,46501246,10207,Active,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
135,2300,1,3,,46501246,10207,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
136,2314,1,2,,26756894,10207,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
137,2314,1,2,,26756894,10207,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
138,2315,1,2,,26756894,10207,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
139,2315,1,2,,26756894,10207,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
140,2380,1,2,,46501246,10207,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
141,2435,1,2,,46501246,10207,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
142,2445,1,2,,46501246,10207,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
143,2451,1,2,,26756894,10207,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
144,2462,1,1,,46501246,10207,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
145,2462,1,1,,46501246,10207,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
146,2472,1,2,,26756894,10207,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
147,2517,2,1,,26756894,10207,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
148,2520,1,4,,46501246,10207,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
149,2521,1,3,,46501246,10207,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
150,2524,1,2,,46501246,10207,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
151,2528,1,2,,26756894,10207,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
152,2540,1,2,,46501246,10207,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
153,2544,1,2,,46501246,10207,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
154,2546,1,1,,26756894,10207,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
155,2549,1,1,,26756894,10207,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
156,2550,1,3,,46501246,10207,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
157,2551,1,1,,26756894,10207,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
158,2553,1,2,,46501246,10207,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
159,2557,1,3,,46501246,10207,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
160,2563,1,1,,46501246,10207,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
161,2599,1,2,,46501246,10207,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
162,2606,1,2,,46501246,10207,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
163,2629,1,1,,46501246,10207,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
164,2642,1,2,,46501246,10207,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
165,2648,1,2,,46501246,10207,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
166,2650,2,1,,46501246,10207,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
167,2661,1,1,,46501246,10207,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
168,2690,1,2,,46501246,10207,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
169,2716,1,1,,46501246,10207,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
170,2717,1,2,,46501246,10207,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
171,2718,1,1,,46501246,10207,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
172,2751,2,2,,46501246,10207,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
173,2796,1,4,,46501246,10207,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
174,2797,1,2,,46501246,10207,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
175,2805,2,2,,46501246,10207,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
176,2806,2,2,,46501246,10207,Active,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
177,2825,1,2,,46501246,10207,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
178,19840,3,4,,103220535,10207,Unspecified,,,,,Partition coefficient of compound in octanol and water by Fragmental method of Leo/Hansch,Other,12639543.0,
179,48375,3,7,,103220535,10207,Unspecified,,,,,Inhibitory activity against Cathepsin G (CatG) at 63 uM concentration,Other,1578486.0,
180,52627,3,7,,103220535,10207,Unspecified,,,,,Inhibitory activity against Chymotrypsinogen at 63 uM concentration,Other,1578486.0,
181,67321,3,7,,103220535,10207,Unspecified,,,,,Inhibitory activity against Human Leukocyte Elastase (HLE) at 63 uM concentration,Other,1578486.0,
182,67653,3,8,,103220535,10207,Unspecified,,,,,Inhibitory activity against Porcine Pancreatic Elastase (PPE) at 63 uM concentration,Other,1578486.0,
183,102409,4,8,,103220535,10207,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 1 uM,Other,11459643.0,
184,102410,4,8,,103220535,10207,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 10 uM,Other,11459643.0,
185,102411,4,8,,103220535,10207,Unspecified,,,,,Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 3 uM,Other,11459643.0,
186,132503,6,2,,103220535,10207,Unspecified,,,10.0,IC50,"Compound was tested for inhibitory activity against nitric oxide production in LPS-activated mouse peritoneal macrophages (*,showed cytotoxicity at 30 uM)",Confirmatory,10714491.0,
187,134176,3,3,,103220535,10207,Unspecified,,,,,Compound (at 10 uM) was tested for inhibition against nitric oxide production in LPS-activated mouse peritoneal macrophages,Other,10714491.0,
188,260049,3,6,,103220535,10207,Inactive,,,,,Inhibitory activity on PDGF-induced ERK phosphorylation in NIH3T3 cells at 20 uM,Other,16275083.0,
189,260050,3,7,,103220535,10207,Active,,,,,Inhibitory activity on EGF-induced ERK phosphorylation in prostate cancer PC3 cell line at 20 uM,Other,16275083.0,
190,260051,5,4,,103220535,10207,Unspecified,,,,,Antiproliferative activity against human epidermal carcinoma A431 cell line at 20 uM by MTT method,Other,16275083.0,
191,260052,5,4,,103220535,10207,Unspecified,,,,,Antiproliferative activity against prostate cancer PC3 cell line at 20 uM by MTT method,Other,16275083.0,
192,260053,3,3,,103220535,10207,Unspecified,,,,,Antifungal activity against Fusarium oxysporum at 0.5 mg/ml,Other,16275083.0,
193,260054,3,3,,103220535,10207,Unspecified,,,,,Antifungal activity against Gibberella zeae at 0.5 mg/ml,Other,16275083.0,
194,260055,3,3,,103220535,10207,Unspecified,,,,,Antifungal activity against Phytopthora infestans at 0.5 mg/ml,Other,16275083.0,
195,285171,6,2,,103220535,10207,Unspecified,,,,,Activity against planktonic Streptococcus mutans LMG 14558,Other,17220400.0,
196,285177,3,3,,103220535,10207,Unspecified,,,,,Effect on Streptococcus mutans LMG 14558 assessed as inhibition of biofilm formation in modified Robbin's device at 50 ug/ml relative to BHIS control,Other,17220400.0,
197,334144,6,3,,103220535,10207,Active,,,24.4,IC50,Inhibition of Sprague-Dawley rat cytosolic alcohol dehydrogenase,Confirmatory,,
198,334145,9,5,,103220535,10207,Active,118497.0,29651.0,6.0,IC50,Inhibition of Sprague-Dawley rat cytosolic aldehyde dehydrogenase,Confirmatory,,
199,335922,6,1,,103220535,10207,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of arachidonic acid-stimulated platelet aggregation pretreated 2 mins before arachidonic acid challenge,Other,2213033.0,
200,335923,6,1,,103220535,10207,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of ADP-stimulated platelet aggregation pretreated 2 mins before ADP challenge,Other,2213033.0,
201,335924,6,1,,103220535,10207,Unspecified,,,,,Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of collagen-stimulated platelet aggregation pretreated 2 mins before collagen challenge,Other,2213033.0,
202,343962,3,5,,103220535,10207,Unspecified,,,,,Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells,Other,18556196.0,
203,363328,6,2,,103220535,10207,Active,,,8.7,IC50,Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay,Confirmatory,17949858.0,
204,363329,6,2,,103220535,10207,Active,,,10.0,IC50,Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay,Confirmatory,17949858.0,
205,375433,9,5,,103220535,10207,Unspecified,21263835.0,64805.0,10.0,Ki,Displacement of [3H]PSB0413 from human platelet P2Y12 receptor,Confirmatory,19463000.0,
206,375434,4,7,,103220535,10207,Unspecified,21263835.0,64805.0,,,Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM,Other,19463000.0,
207,434955,1,2,,46501246,10207,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
208,434962,1,2,,46501246,10207,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
209,434970,1,2,,46501246,10207,Inactive,124487323.0,76768.0,,,Single concentration confirmation of uHTS hits from a small molecule activators of mouse intestinal alkaline phosphatase via a luminescent assay,Screening,,
210,434971,1,2,,46501246,10207,Active,124487323.0,76768.0,,,Single concentration confirmation of uHTS hits from a small molecule inhibitors of mouse intestinal alkaline phosphatase via a luminescent assay,Screening,,
211,434973,1,3,,46501246,10207,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
212,434989,1,1,,46501246,10207,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
213,435003,1,3,,46501246,10207,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
214,435005,1,1,,46501246,10207,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
215,435022,2,2,,46501246,10207,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
216,435030,1,2,,46501246,10207,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
217,435030,1,2,,46501246,10207,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
218,449728,1,2,,46501246,10207,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
219,449739,1,2,,46501246,10207,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
220,449762,1,2,,46501246,10207,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
221,449763,1,3,,46501246,10207,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
222,449768,1,1,,46501246,10207,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
223,463079,1,2,,46501246,10207,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
224,463082,1,1,,46501246,10207,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
225,463104,1,2,,46501246,10207,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
226,463111,1,1,,46501246,10207,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
227,463141,1,2,,46501246,10207,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
228,463165,1,1,,46501246,10207,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
229,463190,1,2,,46501246,10207,Active,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
230,463195,1,2,,46501246,10207,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
231,463203,1,1,,46501246,10207,Inactive,49574532.0,2931.0,300.0,AC50_uM,Luminescence Cell-Free  Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alpha,Confirmatory,,
232,463205,1,1,,46501246,10207,Inactive,,,300.0,AC50_uM,Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-glo,Confirmatory,,
233,463210,1,2,,46501246,10207,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
234,463212,1,1,,46501246,10207,Active,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
235,463213,1,3,,46501246,10207,Active,285809906.0,856395.0,,,Single concentration confirmation of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
236,463218,1,2,,46501246,10207,Active,285814664.0,855751.0,,,Single concentration confirmation of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
237,485270,1,1,,46501246,10207,Active,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
238,485272,1,1,,46501246,10207,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
239,485273,2,1,,46501246,10207,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
240,485275,1,3,,46501246,10207,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
241,485281,1,1,,26756894,10207,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
242,485290,1,1,,26756894,10207,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
243,485317,1,2,,46501246,10207,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
244,485346,1,1,,46501246,10207,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
245,485346,1,1,,46501246,10207,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
246,488785,1,1,,46501246,10207,Active,124487323.0,76768.0,2.88,IC50_Mean,Dose Response confirmation of uHTS hits from a small molecule inhibitors of mouse intestinal alkaline phosphatase via a luminescent assay,Confirmatory,,
247,488847,1,3,,46501246,10207,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
248,488876,1,2,,46501246,10207,Inactive,124376142.0,248.0,100.0,IC50_Mean,Dose Response confirmation of uHTS inhibitors of Mouse Intestinal Alkaline Phosphatase using Human Intestinal Alkaline Phosphatase,Confirmatory,,
249,488879,1,1,,46501246,10207,Inactive,157266296.0,251.0,100.0,IC50_Mean,Dose Response confirmation of uHTS inhibitors of Mouse Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase,Confirmatory,,
250,488890,1,2,,46501246,10207,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
251,488906,1,1,,46501246,10207,Inactive,116734717.0,249.0,100.0,IC50_Mean,Dose Response confirmation of uHTS inhibitors of Mouse Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase.,Confirmatory,,
252,488922,1,2,,46501246,10207,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
253,488975,1,2,,46501246,10207,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
254,488977,1,2,,46501246,10207,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
255,489030,2,1,,46501246,10207,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
256,489031,2,1,,46501246,10207,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
257,493005,1,1,,46501246,10207,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
258,493011,1,1,,46501246,10207,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
259,493012,1,1,,46501246,10207,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
260,493036,1,2,,46501246,10207,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
261,493091,1,1,,46501246,10207,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
262,493098,1,1,,46501246,10207,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
263,493160,1,1,,46501246,10207,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
264,493187,1,2,,46501246,10207,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
265,504327,1,1,,26756894,10207,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
266,504339,1,1,,46501246,10207,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
267,504406,1,1,,46501246,10207,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
268,504408,2,1,,46501246,10207,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
269,504444,1,1,,46501246,10207,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
270,504462,1,1,,46501246,10207,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
271,504648,1,1,,46501246,10207,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
272,504690,1,3,,46501246,10207,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
273,504720,1,1,,46501246,10207,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
274,504845,1,1,,46501246,10207,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
275,504847,1,1,,26756894,10207,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
276,504847,1,1,,46501246,10207,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
277,504891,1,1,,46501246,10207,Inconclusive,5453898.0,5300.0,17.7828,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
278,504894,1,1,,46501246,10207,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
279,504937,1,2,,46501246,10207,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
280,540253,1,1,,46501246,10207,Inconclusive,5031833.0,10073.0,31.6228,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
281,540253,1,1,,46501246,10207,Inconclusive,5453555.0,5901.0,31.6228,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
282,540253,1,1,,46501246,10207,Inconclusive,19923142.0,3837.0,31.6228,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
283,540263,1,1,,46501246,10207,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
284,540263,1,1,,46501246,10207,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
285,540267,1,1,,46501246,10207,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
286,540303,1,1,,46501246,10207,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
287,540303,1,1,,46501246,10207,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
288,540303,1,1,,46501246,10207,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
289,540317,1,1,,46501246,10207,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
290,551520,11,2,,103220535,10207,Unspecified,357529586.0,58819.0,180.0,IC50,Inhibition of rat liver cytosolic TrxR1 by spectrophotometry,Confirmatory,21106380.0,
291,551521,11,2,,103220535,10207,Unspecified,172045556.0,50551.0,200.0,IC50,Inhibition of rat liver mitochondrial TrxR2 by spectrophotometry,Confirmatory,21106380.0,
292,588413,1,2,,46501246,10207,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
293,588453,1,1,,46501246,10207,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
294,588456,1,1,,46501246,10207,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
295,588473,1,1,,46501246,10207,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
296,588473,1,1,,46501246,10207,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
297,588475,1,2,,46501246,10207,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
298,588475,1,2,,46501246,10207,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
299,588511,1,2,,46501246,10207,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
300,588513,1,1,,26756895,10207,Inconclusive,348019627.0,2099.0,3.9811,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
301,588514,1,1,,26756895,10207,Active,348019627.0,2099.0,19.9526,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
302,588515,1,1,,26756895,10207,Inconclusive,124375976.0,367.0,70.7946,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
303,588516,1,1,,26756895,10207,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
304,588526,1,1,,26756895,10207,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
305,588527,1,1,,26756895,10207,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
306,588532,1,1,,26756895,10207,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
307,588533,1,1,,26756895,10207,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
308,588534,1,1,,26756895,10207,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
309,588535,1,1,,26756895,10207,Inconclusive,216409690.0,5467.0,0.3981,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
310,588536,1,1,,26756895,10207,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
311,588537,1,1,,26756895,10207,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
312,588541,1,1,,26756895,10207,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
313,588543,1,1,,26756895,10207,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
314,588544,1,1,,26756895,10207,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
315,588545,1,1,,26756895,10207,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
316,588546,1,1,,26756895,10207,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
317,588547,1,1,,26756895,10207,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
318,588579,1,1,,26756894,10207,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
319,588579,1,1,,46501246,10207,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
320,588590,1,1,,46501246,10207,Inconclusive,154350220.0,11201.0,19.9526,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
321,588591,1,1,,46501246,10207,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
322,588627,1,1,,46501246,10207,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
323,588675,1,1,,46501246,10207,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
324,588676,1,1,,46501246,10207,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
325,588795,1,1,,46501246,10207,Inconclusive,4758356.0,2237.0,50.1187,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
326,588855,1,1,,46501246,10207,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
327,588856,1,1,,46501246,10207,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
328,602179,1,2,,46501246,10207,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
329,602233,1,1,,46501246,10207,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
330,602310,1,2,,46501246,10207,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
331,602313,1,1,,46501246,10207,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
332,602332,1,1,,26756894,10207,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
333,602332,1,1,,46501246,10207,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
334,624170,1,1,,46501246,10207,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
335,624171,1,1,,46501246,10207,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
336,624172,1,1,,46501246,10207,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
337,624173,1,3,,46501246,10207,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
338,624178,1,1,,46501246,10207,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
339,624202,1,1,,46501246,10207,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
340,624246,1,1,,46501246,10207,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
341,624263,1,1,,46501246,10207,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
342,624263,1,1,,46501246,10207,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
343,624288,1,1,,46501246,10207,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
344,624291,1,1,,46501246,10207,Inactive,121312.0,1081.0,,Potency,qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy,Confirmatory,,
345,624296,1,1,,46501246,10207,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
346,624297,1,1,,46501246,10207,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
347,624417,1,1,,46501246,10207,Inactive,1724069.0,2740.0,28.1838,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
348,624418,1,1,,46501246,10207,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
349,624463,1,1,,46501246,10207,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
350,624464,1,1,,46501246,10207,Active,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
351,624465,1,1,,46501246,10207,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
352,651550,1,1,,46501246,10207,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
353,651631,4,1,,144212717,10207,Inconclusive,269849759.0,7157.0,6.859,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
354,651632,4,1,,144212717,10207,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
355,651633,4,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
356,651634,4,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
357,651635,1,3,,46501246,10207,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
358,651644,1,1,,46501246,10207,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
359,651724,1,1,,46501246,10207,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
360,651725,1,1,,46501246,10207,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
361,651741,1,1,,26756895,10207,Active,20149576.0,4780.0,12.1972,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
362,651743,1,1,,26756895,10207,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
363,651749,1,1,,26756895,10207,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
364,651751,1,1,,26756895,10207,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
365,651768,1,2,,46501246,10207,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
366,651777,1,1,,26756895,10207,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
367,651778,1,1,,26756895,10207,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
368,651819,1,1,,46501246,10207,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
369,651820,1,1,,46501246,10207,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
370,651838,1,1,,26756895,10207,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
371,651838,1,1,1.0,26756895,10207,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
372,651838,1,1,2.0,26756895,10207,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
373,651838,1,1,3.0,26756895,10207,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
374,651838,1,1,4.0,26756895,10207,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
375,651838,1,1,5.0,26756895,10207,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
376,651838,1,1,6.0,26756895,10207,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
377,651838,1,1,7.0,26756895,10207,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
378,651838,1,1,8.0,26756895,10207,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
379,651965,1,1,,46501246,10207,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
380,652025,1,1,,46501246,10207,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
381,652048,1,2,,46501246,10207,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
382,652051,1,1,,46501246,10207,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
383,652054,1,1,,46501246,10207,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
384,652104,1,1,,46501246,10207,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
385,652105,1,1,,46501246,10207,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
386,652106,1,1,,46501246,10207,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
387,658253,2,4,,103220535,10207,Active,,,20.8,EC50,Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay,Confirmatory,22445328.0,
388,658255,2,3,,103220535,10207,Unspecified,,,50.0,CC50,Cytotoxicity against human Huh7.5.1 cells by MTT assay,Confirmatory,22445328.0,
389,660311,2,3,,103220535,10207,Unspecified,,,20.0,IC50,Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay,Confirmatory,24900344.0,
390,660312,2,3,,103220535,10207,Unspecified,,,20.0,IC50,Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay,Confirmatory,24900344.0,
391,660313,2,3,,103220535,10207,Unspecified,,,20.0,IC50,Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay,Confirmatory,24900344.0,
392,660314,2,3,,103220535,10207,Unspecified,,,20.0,IC50,Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay,Confirmatory,24900344.0,
393,660315,2,3,,103220535,10207,Unspecified,,,100.0,IC50,Cytotoxicity against human NAR cells after 24 hrs by XTT assay,Confirmatory,24900344.0,
394,660317,1,4,,103220535,10207,Unspecified,,,,,Cytotoxicity against doxorubicin-resistant human MCF7 cells assessed as cell viability at 20 uM after 24 hrs by XTT assay,Other,24900344.0,
395,660318,1,4,,103220535,10207,Unspecified,,,,,Cytotoxicity against human SKOV3 cells assessed as cell viability at 20 uM after 24 hrs by XTT assay,Other,24900344.0,
396,660319,1,3,,103220535,10207,Unspecified,,,,,Cytotoxicity against doxorubicin-resistant human NAR cells assessed as cell viability at 100 uM after 24 hrs by XTT assay,Other,24900344.0,
397,660321,1,3,,103220535,10207,Inactive,,,,,Binding affinity to Escherichia coli pBR322 DNA assessed as DNA migration at 200 uM after 15 mins by agarose gel electrophoresis,Other,24900344.0,
398,660324,1,3,,103220535,10207,Unspecified,,,,,Cytotoxicity against human lymphocytes assessed as cell viability at 20 uM after 24 hrs by XTT assay relative to untreated control,Other,24900344.0,
399,660326,1,3,,103220535,10207,Unspecified,,,,,Toxicity in Wistar rat erythrocytes assessed as hemolysis at 50 uM after 1 hr,Other,24900344.0,
400,686970,1,2,,46501246,10207,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
401,686971,1,2,,46501246,10207,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
402,686978,1,1,,46501246,10207,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
403,686979,1,1,,46501246,10207,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
404,697852,1,7,,103220535,10207,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
405,697853,1,7,,103220535,10207,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
406,720504,1,1,,46501246,10207,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
407,720516,2,1,,144212717,10207,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
408,720532,1,1,,26756894,10207,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
409,720533,1,1,,26756894,10207,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
410,720542,1,2,,46501246,10207,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
411,720551,1,2,,46501246,10207,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
412,720552,2,1,,144212717,10207,Active,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
413,720553,1,2,,46501246,10207,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
414,720579,2,1,,46501246,10207,Inactive,222762.0,3707576.0,11.2202,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
415,720580,1,1,,46501246,10207,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
416,720634,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
417,720635,2,1,,144212717,10207,Active,,,0.8635,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
418,720636,1,1,,26756895,10207,Inconclusive,20149576.0,4780.0,34.3762,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
419,720637,2,1,,144212717,10207,Active,,,1.7903,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
420,720653,1,1,,26756895,10207,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
421,720659,1,1,,26756895,10207,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
422,720674,2,2,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
423,720675,2,2,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
424,720678,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
425,720679,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
426,720680,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
427,720681,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
428,720682,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
429,720683,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
430,720684,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
431,720685,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
432,720686,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
433,720687,2,2,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
434,720691,4,1,,144212717,10207,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
435,720692,3,1,,144212717,10207,Inconclusive,311348376.0,2908.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
436,720693,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
437,720707,1,2,,46501246,10207,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
438,720708,1,2,,46501246,10207,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
439,720709,1,2,,46501246,10207,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
440,720711,1,2,,46501246,10207,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
441,720719,2,1,,144212717,10207,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
442,720725,2,1,,144212717,10207,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
443,736936,1,6,,103220535,10207,Unspecified,584716.0,83817.0,,,Inhibition of AChE in rat cortex using acetylthiocholine iodide as substrate at 100 ug/ml preincubated with enzyme for 10 mins prior to substrate addition by Ellman's colorimetric method,Other,23380475.0,
444,743012,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
445,743014,3,1,,144212717,10207,Inconclusive,,,27.305999999999997,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
446,743015,3,1,,144212717,10207,Active,,,24.3365,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
447,743033,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
448,743035,2,1,,144212717,10207,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
449,743036,2,1,,144212717,10207,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
450,743040,3,1,,144212717,10207,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
451,743041,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
452,743042,3,1,,144212717,10207,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
453,743053,2,1,,144212717,10207,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
454,743054,2,1,,144212717,10207,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
455,743063,2,1,,144212717,10207,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
456,743064,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
457,743065,3,1,,144212717,10207,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
458,743066,3,1,,144212717,10207,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
459,743067,2,1,,144212717,10207,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
460,743069,2,1,,144212717,10207,Inconclusive,348019627.0,2099.0,12.2998,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
461,743074,2,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
462,743075,2,1,,144212717,10207,Inactive,348019627.0,2099.0,34.6739,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
463,743077,2,1,,144212717,10207,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
464,743078,2,1,,144212717,10207,Inconclusive,348019627.0,2099.0,16.0903,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
465,743079,3,1,,144212717,10207,Inconclusive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
466,743080,3,1,,144212717,10207,Inconclusive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
467,743081,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
468,743083,3,1,,144212717,10207,Inactive,119597822.0,1588.0,7.6959,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
469,743084,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
470,743085,3,1,,144212717,10207,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
471,743086,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
472,743091,2,1,,144212717,10207,Inconclusive,348019627.0,2099.0,22.9752,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
473,743094,3,1,,144212717,10207,Inconclusive,216409692.0,5468.0,6.9167,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
474,743122,2,1,,144212717,10207,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
475,743139,2,1,,144212717,10207,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
476,743140,2,1,,144212717,10207,Active,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
477,743191,3,1,,144212717,10207,Inconclusive,216409692.0,5468.0,30.8956,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
478,743194,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
479,743199,2,1,,144212717,10207,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
480,743202,4,1,,144212717,10207,Inconclusive,20149576.0,4780.0,2.169,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
481,743203,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
482,743209,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
483,743210,4,1,,144212717,10207,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
484,743211,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
485,743212,3,1,,144212717,10207,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
486,743213,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
487,743215,3,1,,144212717,10207,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
488,743217,3,1,,144212717,10207,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
489,743218,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
490,743219,3,1,,144212717,10207,Active,20149576.0,4780.0,5.1435,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
491,743220,3,1,,144212717,10207,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
492,743221,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
493,743222,3,1,,144212717,10207,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
494,743223,3,1,,144212717,10207,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
495,743224,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
496,743225,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
497,743226,2,1,,144212717,10207,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
498,743227,2,1,,144212717,10207,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
499,743228,3,1,,144212717,10207,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
500,743239,2,1,,144212717,10207,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
501,743240,2,1,,144212717,10207,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
502,743241,2,1,,144212717,10207,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
503,743242,2,1,,144212717,10207,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
504,743255,1,1,,46501246,10207,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
505,743266,1,2,,46501246,10207,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
506,743279,1,2,,46501246,10207,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
507,743288,1,1,,26756895,10207,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
508,743292,1,1,,26756895,10207,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
509,743344,1,1,,174006955,10207,Inactive,,,0.006,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
510,743345,1,1,,174006955,10207,Inactive,,,16.7744,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
511,743346,1,1,,174006955,10207,Inactive,,,10.5839,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
512,743347,1,1,,174006955,10207,Inactive,,,13.3244,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
513,753308,1,1,,103220535,10207,Unspecified,,,132.0,IC50,Inhibition of recombinant SARS coronavirus 3C-like protease trans-cleavage activity by ELISA,Confirmatory,23647823.0,
514,755276,1,1,,103220535,10207,Active,,,,,Antidiabetic nephropathic activity in rat HBZY-1 cells assessed as inhibition of high concentration glucose-induced IL-6 production at 10 uM treated 1 hr before glucose challenge measured after 24 hrs by ELISA,Other,23683594.0,
515,1062995,1,2,,103220535,10207,Unspecified,,,55.0,IC50,Antiplasmodial activity against chloroquine-resistant ring stage Plasmodium falciparum Dd2 after 72 hrs by SYBR Green 1-based fluorescence assay,Confirmatory,24326280.0,
516,1062996,1,2,,103220535,10207,Active,,,26.0,IC50,Cytotoxicity against human A2780 cells,Confirmatory,24326280.0,
517,1072523,2,1,,103220535,10207,Unspecified,,,,IC50,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production,Confirmatory,24549242.0,
518,1072528,2,1,,103220535,10207,Unspecified,,,,IC50,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion,Confirmatory,24549242.0,
519,1072529,2,1,,103220535,10207,Unspecified,,,,IC50,Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion,Confirmatory,24549242.0,
520,1072538,1,4,,103220535,10207,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase using xanthine as substrate at 50 ug/ml,Other,24556143.0,
521,1072539,1,4,,103220535,10207,Unspecified,109940048.0,280960.0,,,Inhibition of bovine xanthine oxidase using xanthine as substrate measured for 6 mins at 50 uM at 25 degC by spectrophotometry,Other,24556143.0,
522,1083211,3,1,,103220535,10207,Inactive,,,,,Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition in King's B full medium measured at pH 7.2 after overnight incubation by suspension culture assay,Other,23163769.0,
523,1159509,1,1,,144212717,10207,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
524,1159515,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
525,1159516,1,1,,144212717,10207,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
526,1159517,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
527,1159518,1,1,,144212717,10207,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
528,1159519,1,1,,144212717,10207,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
529,1159520,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
530,1159521,1,1,,144212717,10207,Inactive,15928672.0,19885.0,38.5708,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
531,1159523,1,1,,144212717,10207,Inconclusive,15928672.0,19885.0,3.43762,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
532,1159524,1,1,,46501246,10207,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
533,1159525,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
534,1159526,1,1,,144212717,10207,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
535,1159527,1,1,,144212717,10207,Inconclusive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
536,1159528,1,1,,144212717,10207,Inconclusive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
537,1159529,1,1,,144212717,10207,Inconclusive,,,6.1645,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
538,1159531,1,1,,144212717,10207,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
539,1159551,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
540,1159552,1,1,,144212717,10207,Inactive,325495463.0,5914.0,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
541,1159553,2,1,,144212717,10207,Inconclusive,325495463.0,5914.0,38.5708,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
542,1159555,1,1,,144212717,10207,Inconclusive,325495463.0,5914.0,24.3365,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
543,1172903,1,1,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as reduction in scopolamine-induced escape latency at 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test",Other,25453793.0,
544,1172905,1,1,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as reversal of scopolamine-induced effect on spatial memory performance at 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test relative to sham control",Other,25453793.0,
545,1172906,1,1,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as reduction in scopolamine-induced impairment in spatial learning and memory at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days measured at day 5 by Morris water maze test relative to sham control",Other,25453793.0,
546,1172907,1,1,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in time spent in target quadrant at 50 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days measured at day 5 by Morris water maze test relative to sham control",Other,25453793.0,
547,1172909,1,1,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in time spent in platform crossing at 50 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days measured at day 5 by Morris water maze test relative to sham control",Other,25453793.0,
548,1172911,1,1,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in swim speed at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days measured at day 5 by Morris water maze test relative to sham control",Other,25453793.0,
549,1172912,1,2,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in SOD level in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days relative to control",Other,25453793.0,
550,1172913,1,2,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in GPx level in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days relative to control",Other,25453793.0,
551,1172914,1,2,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as reduction in scopolamine-induced increase in MDA level in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days relative to control",Other,25453793.0,
552,1172918,1,2,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as reversal of scopolamine-induced increase in AChE activity in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days",Other,25453793.0,
553,1172919,1,2,,103220535,10207,Active,,,,,"Neuroprotective effect in Kunming mouse assessed as reversal of scopolamine-induced reduction in ACh level in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days",Other,25453793.0,
554,1172922,1,2,,103220535,10207,Inactive,,,,,"Neuroprotective effect in Kunming mouse assessed as reversal of scopolamine-induced increase in AChE activity in hippocampus at 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days relative to sham control",Other,25453793.0,
555,1172923,1,2,,103220535,10207,Unspecified,113037.0,43.0,,,Inhibition of AChE (unknown origin) at 40 ug/ml by Ellman's method,Other,25453793.0,
556,1172924,1,2,,103220535,10207,Unspecified,113037.0,43.0,,,Inhibition of AChE (unknown origin) by Ellman's method,Other,25453793.0,
557,1172925,1,1,,103220535,10207,Unspecified,,,,,Cytotoxicity against rat PC12 cells at 1 to 20 ug/ml by MTT assay,Other,25453793.0,
558,1172926,1,1,,103220535,10207,Unspecified,,,,,Cytoprotective effect against H2O2-induced cell death in rat PC12 cells at 5 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by MTT assay,Other,25453793.0,
559,1172927,1,1,,103220535,10207,Unspecified,,,,,Cytoprotective effect against H2O2-induced cell death in rat PC12 cells at 10 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by MTT assay,Other,25453793.0,
560,1172928,1,1,,103220535,10207,Unspecified,,,,,Cytoprotective effect against H2O2-induced cell death in rat PC12 cells at 20 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by MTT assay,Other,25453793.0,
561,1172930,1,1,,103220535,10207,Unspecified,,,,,Inhibition of H2O2-induced NO production in rat PC12 cells incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control,Other,25453793.0,
562,1172931,1,1,,103220535,10207,Unspecified,,,,,Inhibition of H2O2-induced NO production in rat PC12 cells at 5 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control,Other,25453793.0,
563,1172932,1,1,,103220535,10207,Unspecified,,,,,Inhibition of H2O2-induced NO production in rat PC12 cells at 10 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control,Other,25453793.0,
564,1172933,1,1,,103220535,10207,Unspecified,,,,,Inhibition of H2O2-induced NO production in rat PC12 cells at 20 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control,Other,25453793.0,
565,1172935,1,1,,103220535,10207,Active,,,,,Inhibition of H2O2-induced LDH release in rat PC12 cells at 5 to 20 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control,Other,25453793.0,
566,1172937,1,1,,103220535,10207,Unspecified,,,,,Inhibition of intracellular ROS generation in rat PC12 cells at 5 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by fluorescence assay relative to control,Other,25453793.0,
567,1172938,1,1,,103220535,10207,Unspecified,,,,,Inhibition of intracellular ROS generation in rat PC12 cells at 10 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by fluorescence assay relative to control,Other,25453793.0,
568,1172939,1,1,,103220535,10207,Unspecified,,,,,Inhibition of intracellular ROS generation in rat PC12 cells at 20 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by fluorescence assay relative to control,Other,25453793.0,
569,1172941,1,1,,103220535,10207,Unspecified,,,,,Neuroprotective effect in po dosed Kunming mouse assessed as reduction in scopolamine-induced escape latency administered qd for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test,Other,25453793.0,
570,1172942,1,1,,103220535,10207,Unspecified,,,,,Neuroprotective effect in po dosed Kunming mouse assessed as increase in scopolamine-induced reduction in time spent in target quadrant administered qd for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test,Other,25453793.0,
571,1172943,1,1,,103220535,10207,Unspecified,,,,,Neuroprotective effect in po dosed Kunming mouse assessed as increase in scopolamine-induced reduction in time spent in platform crossing administered qd for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test,Other,25453793.0,
572,1224824,1,1,,174006955,10207,Inactive,,,0.4686,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
573,1224825,1,1,,174006955,10207,Inactive,,,4.6859,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
574,1224834,3,1,,144212717,10207,Inconclusive,,,21.6899,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
575,1224835,1,1,,144212717,10207,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
576,1224836,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
577,1224837,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
578,1224838,1,1,,144212717,10207,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
579,1224839,1,1,,144212717,10207,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
580,1224840,3,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
581,1224841,3,1,,144212717,10207,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
582,1224842,3,1,,144212717,10207,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
583,1224843,1,1,,144212717,10207,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
584,1224844,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
585,1224845,1,1,,144212717,10207,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
586,1224846,1,1,,144212717,10207,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
587,1224847,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
588,1224848,3,1,,144212717,10207,Inconclusive,325495545.0,2101.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
589,1224849,3,1,,144212717,10207,Inactive,325495545.0,2101.0,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
590,1224857,2,1,,174006955,10207,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
591,1224859,2,1,,174006955,10207,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
592,1224867,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
593,1224868,1,1,,144212717,10207,Inconclusive,,,27.5357,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
594,1224869,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
595,1224870,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
596,1224871,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
597,1224872,1,1,,144212717,10207,Inconclusive,,,27.5357,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
598,1224873,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
599,1224874,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
600,1224875,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
601,1224876,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
602,1224877,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
603,1224878,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
604,1224879,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
605,1224880,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
606,1224881,1,1,,144212717,10207,Inconclusive,,,0.2454,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
607,1224882,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
608,1224883,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
609,1224884,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
610,1224885,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
611,1224886,1,1,,144212717,10207,Inconclusive,,,27.5357,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
612,1224887,1,1,,144212717,10207,Inconclusive,,,43.6412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
613,1224888,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
614,1224889,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
615,1224890,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
616,1224892,1,1,,144212717,10207,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
617,1224893,1,1,,144212717,10207,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
618,1224894,1,1,,144212717,10207,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
619,1224895,1,1,,144212717,10207,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
620,1224896,1,1,,144212717,10207,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
621,1248115,1,1,,103220535,10207,Unspecified,67476665.0,2053.0,,,Inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde at 100 uM measured during 1 hr by fluorescence photometric analysis relative to control,Other,26372074.0,
622,1248116,1,1,,103220535,10207,Active,67476665.0,2053.0,26.8,IC50,Inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde measured during 1 hr by fluorescence photometric analysis,Confirmatory,26372074.0,
623,1248117,1,1,,103220535,10207,Unspecified,67476665.0,2053.0,52.2,Ki,Non-competitive inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde measured during 30 mins by Dixon plot analysis,Confirmatory,26372074.0,
624,1248119,1,1,,103220535,10207,Active,67476665.0,2053.0,,,Non-competitive inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde measured during 30 mins by Lineweaver-Burk plot analysis,Other,26372074.0,
625,1259241,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
626,1259242,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
627,1259243,1,1,,144212717,10207,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
628,1259244,1,1,,144212717,10207,Inactive,348019627.0,2099.0,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
629,1259247,1,1,,144212717,10207,Inconclusive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
630,1259248,1,1,,144212717,10207,Inconclusive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
631,1259252,1,1,,174006955,10207,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
632,1259253,1,1,,174006955,10207,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
633,1259255,1,1,,174006955,10207,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
634,1259256,1,1,,174006955,10207,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
635,1259310,1,1,,333473204,10207,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
636,1259313,1,1,,46501246,10207,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
637,1259364,1,1,,144212717,10207,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
638,1259365,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
639,1259366,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
640,1259367,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
641,1259368,1,1,,144212717,10207,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
642,1259369,1,1,,144212717,10207,Inactive,109731339.0,2737.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
643,1259377,1,1,,144212717,10207,Inconclusive,54288833.0,2100.0,6.1131,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
644,1259378,1,1,,144212717,10207,Inconclusive,54288833.0,2100.0,17.2289,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
645,1259379,1,1,,144212717,10207,Inconclusive,,,19.3312,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
646,1259380,1,1,,144212717,10207,Inconclusive,,,8.6349,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
647,1259381,1,1,,144212717,10207,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
648,1259382,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
649,1259383,1,1,,144212717,10207,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
650,1259384,1,1,,144212717,10207,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
651,1259385,1,1,,144212717,10207,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
652,1259386,1,1,,144212717,10207,Inconclusive,,,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
653,1259387,1,1,,144212717,10207,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
654,1259388,1,1,,144212717,10207,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
655,1259389,1,1,,175607930,10207,Active,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
656,1259390,1,1,,144212717,10207,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
657,1259391,1,1,,144212717,10207,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
658,1259392,1,1,,144212717,10207,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
659,1259393,1,1,,144212717,10207,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
660,1259394,1,1,,144212717,10207,Inconclusive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
661,1259395,1,1,,144212717,10207,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
662,1259396,1,1,,144212717,10207,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
663,1259401,1,1,,144212717,10207,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
664,1259402,1,1,,144212717,10207,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
665,1259403,1,1,,144212717,10207,Active,325495545.0,2101.0,68.5896,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
666,1259404,1,1,,144212717,10207,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
667,1259407,1,1,,363901476,10207,Inactive,,,,,CCRIS mutagenicity studies,Other,,
668,1259408,1,1,,363895640,10207,Inactive,,,,,GENE-TOX mutagenicity studies,Other,,
669,1259416,1,2,,340086056,10207,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
670,1259418,1,1,,340086056,10207,Active,56786138.0,3458.0,16.62,AC50_uM,Toxoplasma gondii at dose in the presence of IFN-y,Confirmatory,,
671,1259420,1,1,,340086056,10207,Inconclusive,56786138.0,3458.0,,AC50_uM,Toxoplasma gondii at dose in the absence of IFN-y,Confirmatory,,
672,1259421,1,1,,340086056,10207,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
673,1259423,1,2,,354796585,10207,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
